Axogen, Inc. is a healthcare company based in the United States that specializes in peripheral nerve regeneration and repair technologies. With an ESG score of 27.7, the company is classified as a medium risk. Axogen offers clinically and economically effective solutions for surgeons and healthcare providers, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. The company's products are available in various countries worldwide.